Predictors of mortality in Acinetobacter baumannii bacteremia

Journal of Microbiology, Immunology and Infection

Volumn 38, Issue 2, 2005, Pages 127-136

  Chen, Hsin Pai ^a   Chen, Te Li ^a   Lai, Chung Hsu ^a   Fung, Chang Phone ^a   Wong, Wing Wai ^a   Yu, Kwok Woon ^b   Liu, Cheng Yi ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Acinetobacter baumannii; Bacteremia; Mortality; Retrospective studies; Risk factors

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CORTICOSTEROID; COTRIMOXAZOLE; CYTOTOXIC AGENT; GENTAMICIN; IMIPENEM; IMMUNOSUPPRESSIVE AGENT; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BACTERIUM ISOLATE; CAUSE OF DEATH; CENTRAL VENOUS CATHETERIZATION; CORRELATION ANALYSIS; FEMALE; HOSPITAL INFECTION; HUMAN; IMMUNE STATUS; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SHOCK; STATISTICAL SIGNIFICANCE; SURGERY; SURVIVAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERIZATION; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; HUMANS; IMMUNOSUPPRESSION; INTENSIVE CARE UNITS; INTUBATION, GASTROINTESTINAL; LENGTH OF STAY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PLATELET COUNT; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; SHOCK; SURGICAL PROCEDURES, OPERATIVE; TAIWAN;

EID: 19944421444     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Beck-Sague CM, Jarvis WR, Brook JH, Culver DH, Potts A, Gay E, et al. Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units. Am J Epidemiol 1990; 132:723-33.
2. Fagon JY, Chastre J, Domart Y, Trouillet JL, Pierre J, Darne C, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989;139: 877-84.
3. Husni RN, Goldstein LS, Arroliga AC, Hall GS, Fatica C, Stoller JK, et al. Risk factors for an outbreak of multidrug-resistant acinetobacter nosocomial pneumonia among intubatedpatients. Chest 1999;115:1378-82.
4. Villers D, Espaze E, Coste-Burel M, Giauffret F, Ninin E, Nicolas F, et al. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med 1998;129:182-9.
5. Kuo LC, Yu CJ, Lee LN, Wang JL, Wang HC, Hsueh PR, et al. Clinical features of pandrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Taiwan. J Formos Med Assoc 2003;102:601-6.
6. Scerpella EG, Wanger AR, Armitige L, Anderlini P, Ericsson CD. Nosocomial outbreak caused by a multiresistant clone of Acinetobacter baumannii: results of the case-control and molecular epidemiologic investigations. Infect Control Hosp Epidemiol 1995;16:92-7.
7. Hsueh PR, Teng LJ, Chen CY, Chen WH, Yu CJ, Ho SW, et al. Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan. Emerg Infect Dis 2002;8:827-32.
8. Okpara AU, Maswoswe JJ. Emergence of multidrug-resistant isolates of Acinetobacter baumannii. Am J Hosp Pharm 1994; 51:2671-5.
9. Lin SY, Wong WW, Fung CP, Liu CE, Liu CY. Acinetobacter calcoaceticus-baumannii complex bacteremia: analysis of 82 cases. J Microbiol Immunol Infect 1998;31:119-24.
10. Koprnova J, Svetlansky I, Babel'a R, Bilikova E, Hanzen J, Zuscakova IJ, et al. Prospective study of antibacterial susceptibility, risk factors and outcome of 157 episodes of Acinetobacter baumannii bacteremia in 1999 in Slovakia. Scand J Infect Dis 2001;33:891-5.
11. Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) 1995;74:340-9.
12. Raad II, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992;15:197-208.
13. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
14. Valero C, Garcia Palomo JD, Matorras P, Fernandez-Mazarrasa C, Gonzalez FC, Farinas MC. Acinetobacter bacteraemia in a teaching hospital, 1989-1998. Eur J Intern Med 2001;12: 425-9.
15. Bouvet PJ, Grimont PA. Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur Microbiol 1987; 138:569-78.
16. National Committee for Clinical Laboratory Standards 2000: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard M7-A5, Wayne, PA.
17. Gross PA, DeMauro PJ, Van Antwerpen C, Wallenstein S, Chiang S. Number of comorbidities as a predictor of nosocomial infection acquisition. Infect Control Hosp Epidemiol 1988;9: 497-500.
18. Pittet D, Thievent B, Wenzel RP, Li N, Gurman G, Suter PM. Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients. Intensive Care Med 1993; 19:265-72.
19. Wang JT, McDonald LC, Chang SC, Ho M. Community-acquired Acinetobacter baumannii bacteremia in adult patients in Taiwan. J Clin Microbiol 2002;40:1526-9.
20. Anstey NM, Currie BJ, Withnall KM. Community-acquired Acinetobacter pneumonia in the Northern Territory of Australia. Clin Infect Dis 1992;14:83-91.
21. Ng TK, Ling JM, Cheng AF, Norrby SR. A retrospective study of clinical characteristics of acinetobacter bacteremia. Scand J Infect Dis Suppl 1996;101:26-32.
22. Tilley PA, Roberts FJ. Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings. Clin Infect Dis 1994;18:896-900.
23. Timsit JF, Garrait V, Misset B, Goldstein FW, Renaud B, Carlet J. The digestive tract is a major site for Acinetobacter baumannii colonization in intensive care unit patients. J Infect Dis 1993; 168:1336-7.
24. Siau H, Yuen KY, Ho PL, Wong SS, Woo PC. Acinetobacter bacteremia in Hong Kong: prospective study and review. Clin Infect Dis 1999;28:26-30.
25. Weinstein MP, Murphy JR, Reller LB, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983; 5:54-70.
26. Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage spread, and relation to antibiotic usage. Clin Infect Dis 2000; 31:101-6.
27. Leibovici L, Konisberger H, Pitlik SD, Samra Z, Drucker M. Patients at risk for inappropriate antibiotic treatment of bacteraemia. J Intern Med 1992;231:371-4.
28. Cisneros JM, Reyes MJ, Pachon J, Becerril B, Caballero FJ, Garcia-Garmendia JL, et al. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis 1996;22:1026-32.